Calton & Associates’s Argan AGX Stock Holding History

Calton & Associates’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-153	Closed	-$6K	–	368
2017 Q4	$6K	Buy	+153	New	+$9.11K	﹤0.01%	1195

Other funds holding AGX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Calton & Associates's AGX Position: Q1 2018 in Review

Calton & Associates sold out of Argan (AGX) in Q1 2018, closing a stake of 153 shares — an estimated $6K sold.

Calton & Associates first reported a position in AGX in Q4 2017 and held it in 1 quarter. The position peaked at $6K in Q4 2017. 164 funds tracked by Wall St. Rank hold AGX as of Q1 2018.

Calton & Associates reported no remaining Argan position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 153 Argan shares in Q1 2018, an estimated $6K.
Calton & Associates first reported a position in Argan in Q4 2017 and held it in 1 quarter.
Calton & Associates's Argan position peaked at $6K in Q4 2017.
164 funds tracked by Wall St. Rank held Argan as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.